Treatment of Hypoxemic Respiratory Failure in Neonates: Past, Present, and Future

This publication is based on discussions at a roundtable meeting supported by a grant from Mallinckrodt Pharmaceuticals, formerly Ikaria, Inc. Presentations and discussions were developed solely by the participants, without grantor input.